SlideShare a Scribd company logo
1 of 1
Download to read offline
IT PROVIDER All Respondents
RAMOS MD,FAUSTINO G
Overall
Section
All Facilities
N = 1074
AHA Region 7
N = 86
AMC
N = 81
Question Mean n Rank Rank Rank
Std Overall 95.4 48 98 99 99
Std Care Provider 97.4 48 99 98 99
Friendliness/courtesy of CP 97.9 48 97 95 98
CP explanations of prob/condition 96.9 48 97 92 99
CP concern for questions/worries 96.8 47 97 92 99
CP efforts to include in decisions 97.8 46 99 99 99
CP information about medications 97.4 39 99 99 99
CP instructions for follow-up care 97.2 45 99 99 99
CP spoke using clear language 97.9 47 98 96 99
Time CP spent with patient 96.8 47 99 99 99
Patients' confidence in CP 97.3 46 97 94 98
Likelihood of recommending CP 97.3 47 98 96 99
Question Analysis - IT PROVIDER: RAMOS MD,FAUSTINO G
Multiple Sites infoEDGE
MEDICAL PRACTICE REPORTMEDICAL PRACTICE REPORT
11/21/2016 10:59:43 EST
For a list of filter and benchmark definitions, click here. 1-800-232-8032
8
All data including past trended data are benchmarked against the
period ending 10/31/2016

More Related Content

What's hot

NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...
NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...
NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...European School of Oncology
 
Medication Safety
Medication SafetyMedication Safety
Medication Safetyrmullenger
 
medication reconciliation
medication reconciliationmedication reconciliation
medication reconciliationMissam Merchant
 
Medication Reconciliation Education
Medication Reconciliation EducationMedication Reconciliation Education
Medication Reconciliation Educationcshowers5608
 
Role of hospital pharmacists in transitions of care
Role of hospital pharmacists in transitions of careRole of hospital pharmacists in transitions of care
Role of hospital pharmacists in transitions of careRosalynn Pangan
 

What's hot (9)

Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)
 
Medication Reconciliation
Medication ReconciliationMedication Reconciliation
Medication Reconciliation
 
NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...
NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...
NY Prostate Cancer Conference - M.H. Hussain - Highlights of Day 2 breakout s...
 
Medication Safety
Medication SafetyMedication Safety
Medication Safety
 
medication reconciliation
medication reconciliationmedication reconciliation
medication reconciliation
 
Medication Reconciliation Education
Medication Reconciliation EducationMedication Reconciliation Education
Medication Reconciliation Education
 
Personalized Medicine
Personalized MedicinePersonalized Medicine
Personalized Medicine
 
Pharmacogenetic Flyer
Pharmacogenetic FlyerPharmacogenetic Flyer
Pharmacogenetic Flyer
 
Role of hospital pharmacists in transitions of care
Role of hospital pharmacists in transitions of careRole of hospital pharmacists in transitions of care
Role of hospital pharmacists in transitions of care
 

Similar to Press Ganey 2016-11 Ramos

Mediation safety - Third Lecture
Mediation safety - Third LectureMediation safety - Third Lecture
Mediation safety - Third LectureKurt Wilson
 
Bringing NGS Testing In-House
Bringing NGS Testing In-HouseBringing NGS Testing In-House
Bringing NGS Testing In-HouseJosh Forsythe
 
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...hivlifeinfo
 
Utility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision supportUtility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision supportHealth Informatics New Zealand
 
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Ovarian Cancer Research Fund Alliance
 
Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...
Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...
Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...Suzanne Hendery
 
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...Schiffon Wong
 
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptxALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptxScientificPathology3
 
Medicare Advantage Ad - Testing Patients with Indications
Medicare Advantage Ad - Testing Patients with IndicationsMedicare Advantage Ad - Testing Patients with Indications
Medicare Advantage Ad - Testing Patients with IndicationsChristian Trygstad
 
Using a Quality Database in Private Practice
Using a Quality Database in Private PracticeUsing a Quality Database in Private Practice
Using a Quality Database in Private PracticeSpectrummedGrp
 
5 dangerous ideas
5 dangerous ideas5 dangerous ideas
5 dangerous ideasWayne Pan
 
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?Office of Health Economics
 
Damian o'connell - Transformation of the global clinical trials footprint in ...
Damian o'connell - Transformation of the global clinical trials footprint in ...Damian o'connell - Transformation of the global clinical trials footprint in ...
Damian o'connell - Transformation of the global clinical trials footprint in ...ipposi
 
Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?
Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?
Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?Sociedad Española de Cardiología
 
Polidocanol Endovenous Microfoam: Where Are We?
Polidocanol Endovenous Microfoam: Where Are We?Polidocanol Endovenous Microfoam: Where Are We?
Polidocanol Endovenous Microfoam: Where Are We?Vein Global
 
Using Enterprise Data To Drive Improvement
Using Enterprise Data To Drive ImprovementUsing Enterprise Data To Drive Improvement
Using Enterprise Data To Drive ImprovementEdgewater
 

Similar to Press Ganey 2016-11 Ramos (20)

Mediation safety - Third Lecture
Mediation safety - Third LectureMediation safety - Third Lecture
Mediation safety - Third Lecture
 
Bringing NGS Testing In-House
Bringing NGS Testing In-HouseBringing NGS Testing In-House
Bringing NGS Testing In-House
 
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
Contemporary Management of HIV. New Data From IDWeek 2018 and Other Fall 2018...
 
Utility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision supportUtility of primary care-based TIA electronic decision support
Utility of primary care-based TIA electronic decision support
 
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
Clinical Trials: Fact vs. Fiction, Courtney Hudson, CEO & Co-Founder, Emergin...
 
Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...
Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...
Becker's Annual Meeting_4-2022 Harnessing the Power of Satisfaction Suzanne H...
 
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
IMPROVING PERFORMANCE OF ALGORITHMS TO POWER UNMET NEED AND EFFECTIVENESS IN ...
 
Intro To Adaptive Design
Intro To Adaptive DesignIntro To Adaptive Design
Intro To Adaptive Design
 
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptxALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
ALERT VALUES IN LAB/ CRITICAL LAB VALUES.pptx
 
Medicare Advantage Ad - Testing Patients with Indications
Medicare Advantage Ad - Testing Patients with IndicationsMedicare Advantage Ad - Testing Patients with Indications
Medicare Advantage Ad - Testing Patients with Indications
 
Using a Quality Database in Private Practice
Using a Quality Database in Private PracticeUsing a Quality Database in Private Practice
Using a Quality Database in Private Practice
 
5 dangerous ideas
5 dangerous ideas5 dangerous ideas
5 dangerous ideas
 
2015 Vivette Escueta enbrel pharmacoepidemiological study protocol - AAPS p...
2015   Vivette Escueta enbrel pharmacoepidemiological study protocol - AAPS p...2015   Vivette Escueta enbrel pharmacoepidemiological study protocol - AAPS p...
2015 Vivette Escueta enbrel pharmacoepidemiological study protocol - AAPS p...
 
Mccaig Woodwell2
Mccaig Woodwell2Mccaig Woodwell2
Mccaig Woodwell2
 
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
Can the US Afford to Ignore Cost-effectiveness Evidence in Health Care?
 
Damian o'connell - Transformation of the global clinical trials footprint in ...
Damian o'connell - Transformation of the global clinical trials footprint in ...Damian o'connell - Transformation of the global clinical trials footprint in ...
Damian o'connell - Transformation of the global clinical trials footprint in ...
 
Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?
Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?
Introducción: de la investigación a la práctica. ¿Qué cambia en la vida real?
 
Polidocanol Endovenous Microfoam: Where Are We?
Polidocanol Endovenous Microfoam: Where Are We?Polidocanol Endovenous Microfoam: Where Are We?
Polidocanol Endovenous Microfoam: Where Are We?
 
Using Enterprise Data To Drive Improvement
Using Enterprise Data To Drive ImprovementUsing Enterprise Data To Drive Improvement
Using Enterprise Data To Drive Improvement
 
National VTE Audit Day: Results and Feedback
National VTE Audit Day: Results and FeedbackNational VTE Audit Day: Results and Feedback
National VTE Audit Day: Results and Feedback
 

Press Ganey 2016-11 Ramos

  • 1. IT PROVIDER All Respondents RAMOS MD,FAUSTINO G Overall Section All Facilities N = 1074 AHA Region 7 N = 86 AMC N = 81 Question Mean n Rank Rank Rank Std Overall 95.4 48 98 99 99 Std Care Provider 97.4 48 99 98 99 Friendliness/courtesy of CP 97.9 48 97 95 98 CP explanations of prob/condition 96.9 48 97 92 99 CP concern for questions/worries 96.8 47 97 92 99 CP efforts to include in decisions 97.8 46 99 99 99 CP information about medications 97.4 39 99 99 99 CP instructions for follow-up care 97.2 45 99 99 99 CP spoke using clear language 97.9 47 98 96 99 Time CP spent with patient 96.8 47 99 99 99 Patients' confidence in CP 97.3 46 97 94 98 Likelihood of recommending CP 97.3 47 98 96 99 Question Analysis - IT PROVIDER: RAMOS MD,FAUSTINO G Multiple Sites infoEDGE MEDICAL PRACTICE REPORTMEDICAL PRACTICE REPORT 11/21/2016 10:59:43 EST For a list of filter and benchmark definitions, click here. 1-800-232-8032 8 All data including past trended data are benchmarked against the period ending 10/31/2016